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Mycotoxin contamination is a worldwide
problem affecting staple crops such as corn
(maize) and small grains (such as wheat), as
well as tree nuts, peanuts, sorghum, and many
others. Many countries regulate the maximum
allowable concentrations of specific mycotox-
ins in food commodities and animal feed.
Until recently, dietary and occupational expo-
sures were the primary areas of concern, but
with growing attention being paid to the
problems associated with indoor molds and
respiratory exposures, researchers are recogniz-
ing that the potential scope of mycotoxin
exposures is broader than originally suspected.
This scope now includes inner-city environ-
ments, with a special foctis on older or poorly
maintained structures that are more suscepti-
ble to harboring molds.
Researchers are also recognizing that spe-
cific groups within a population may be more
vulnerable to exposure than the population at
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r.sibes. teature on aflatoxins myco-
31E n toins pr Aspergillus spp. "As far as
the epidemiEin people goes, the over-
abundance of literecovers aflatoxins," he
scien- says. 'Aflatoxin levels are regulated not only
com- by the Food and DrugAdministration [FDA]
ilated and the U.S. Department of Agriculture
have [USDA] but also in world commerce. I don't
iverse believe that's true for almost any ofthe other
mycotoxins." This emphasis reflects the cen-
c epi- tral role of aflatoxins, especially aflatoxin B,
wn as (AFB,), in mycotoxicological research since
who the early 1960s. Primarily produced by A.
ergo- flavus and A. parasiticus, AFB1 causes liver
[itiL and kidney toxicity in several species and is
most prominently known as a potent liver
carcinogen in humans and animals.
Aspergillus spp. exist worldwide and live offof
cina- a number of crops, although corn and
forms peanuts are the most commonly contaminat-
itified ed commodities. A. flavus and A. parasiticus
:p. as are the most common forms of Aspergillus
tism. and are also capable ofproducing other forms
ecent of aflatoxin. Frequently, there is contam-
bcur- ination with multiple forms of aflatoxin.
- However, regardless of which aflatoxins are
s produced, AFB1 is always among them, and
'rin. it is the most toxic.
-atdry AFB, has been shown to be mutagenic in
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many in vitro model systems and is a proven
carcinogen in many animal species, including
rodents and nonhuman primates. The primary
cancer site in these studies has been the liver,
but in some cases a link has been demonstrat-
ed to lung, kidney, and colon tumors. In
human epidemiological studies, chronic
dietary AFB1 exposures have been strongly
linked to increased incidence of liver cancer.
On the basis ofthis information, AFB1 is clas-
sified as a known human carcinogen by the
International Agency for Research on Cancer
andtheNationalToxicology Program.
The carcinogenic potency ofAFB, is not
manifested until it undergoes activation by
the cytochrome P450 and other oxidative
enzymes. These enzymes transform the afla-
toxin into several products, including the
genotoxic AFB1-exo-8,9-epoxide. This epox-
ide can be shunted by glutathione S-trans-
ferase in the liver, but some will intercalate,
or wedge itself, between DNA base pairs. In
this position, the epoxide rapidly reacts with
the DNA to produce an N7-guanyl adduct.
As demonstrated in several animal models,
these adducts are produced in the greatest
amounts in the liver, although some are also
produced in the kidney or lung. Through
DNA repair and chemical stability mecha-
nisms, AFB1-DNA adducts can be removed
and excreted, but some adducts prove resis-
tant to repair, thereby setting the stage for
mutation events and carcinogenesis. The
potential for AFB1-induced liver cancer is
enhanced in individuals who are also infected
with the hepatitis B virus, a recognized car-
cinogenic virus. In AFB,-exposed popula-
tions, examination of liver tumors reveals a
high incidence of a specific p53 tumor sup-
pressor gene mutation. In AFBI-exposed
individuals infectedwith the hepatitis B virus,
this mutation is associated with 50-60% of
the tumors. Byunderstanding the mechanism
of action ofAFB1, we are identifying guide-
posts for developing intervention strategies,
says Groopman.
The Depth ofthe Field
Not all carcinogenic mycotoxins act through
a genotoxic mechanism, and the fumonisins
provide a case in point. Thefumonisins-BI,
B2, and B-are produced by Fusarium spp.
that grow on corn, most importantly F.
moniliforme. In horses, relatively low expo-
sures to fumonisins have been shown to cause
equine leukoencephalomalacia, a disorder
characterized by brain hemorrhage and
necrosis, followed by death. Horses may also
suffer liver damage and possibly a degree of
kidney damage following dietary exposure to
fumonisins. Liver and kidney effects are more
pronounced in other species such as rodents,
sheep, and rabbits. In swine, high doses of
exposure to fumonisins seem to especially
affect the lungs, leading to porcine pul-
monary edema, a fatal condition in which
fluid collects in the lungs. Low exposures
result in reduced feed consumption. Early
research in animals showed that fumonisins
are potent cancer promoters and potentially
weak initiators. The National Toxicology
Program, along with the FDA's National
Center for Toxicological Research in
Jefferson, Arkansas, and Center for Food
Safety andApplied Nutrition in Washington,
DC, released the results ofa massive study of
the toxicity of fumonisin B1 in May 1999.
Their data showed that fumonisins are car-
cinogenic in rodents, although response dif-
fered byspecies and sex: male rats fed fumon-
isin BI developed liver and kidney cancers,
while female micedeveloped liver cancer.
With regard to human toxicity, epidemi-
ological data from southern Africa and China
suggest a strong link between dietary fumon-
isin exposure and esophageal cancer. Human
epidemiological studies, however, are not
definitive, says Ken Voss, a research pharma-
cologist at the USDA Toxicology and
Mycotoxin Research Unit in Athens,
Georgia. "There are suggestive data that the
fungus and the fumonisins are associatedwith
esophageal cancer," he says. "But there are
enough confounding dietary and environ-
mental factors that the correlation, although
tantalizing and suggestive, is as yet far from
being proven." According to Voss, it has been
shown that fumonisins have measurable and
repeatable toxic effects in animal models.
Fumonisin toxicity seems to be mediated
through inhibition of ceramide synthase, a
key enzyme in the sphingolipid biosynthetic
pathway. "To put it in layman's terms," says
Voss, "the entire metabolism ofsphingolipids
in the cell is disrupted." The potential ramifi-
cations ofthis disruption can be far-reaching,
he says. Until 15-20 years ago, sphingolipids
were considered as having a purely structural
role in cells; however, sphingolipid molecules
and their derivatives are now recognized as
very biologically active compounds. These
compounds, says Voss, either initiate or act as
messengers for many life-or-death decisions
that the cell has to make. Such decisions
include whether the cell embarks on apopto-
sis (cell death) or enters the cell cycle and
replicates. From this point, he says, there are
a host of potential steps and intermediaries
leading to toxigenic orcarcinogenic events.
Fusariumand Its Mycotoxins
In addition to fumonisins, Fusarium spp.
produce several other mycotoxins. F. gramin-
earum and F. culmorum, molds that contami-
nate corn, barley, wheat, and other crops, are
capable of producing the toxins zearalenone
and deoxynivalenol (also called vomitoxin).
Different toxigenic species of Fusarium grow
under different sets of climatic conditions.
"The production of these compounds
depends on a number of different condi-
tions," says Retha Newbold, a supervisory
research biologist at the NIEHS. "Just to
have a product that is contaminated with
mold is not to assume that mycotoxin is pre-
sent. The mold may be there, but it may
produce different levels of mycotoxins, or
even different mycotoxins, depending on ...
different conditions."
Although zearalenone has low acute toxi-
city, it exhibits marked estrogenic effects in
some species. Zearalenone and its metabo-
lites, particularly ox-zearalenol and ,B-zear-
alenol, have been shown to bind to estrogen
receptors in experimental systems. Their
estrogenic potential seems to fall between that
of the endocrine-disrupting organochlorine
pesticides and the more estrogenic compound
diethylstilbestrol. Newbold indicates that the
estrogenicity ofzearalenone and its metabo-
lites differs depending on the tissue and the
species. For example, swine are especially sen-
sitive and experience hyperestrogenism lead-
ing to reproductive problems and infertility
following dietary zearalenone exposures.
Other species such as cattle and sheep seem
more resistant to zearalenone but may still
experience some incidence of infertility,
decreased milk production, and spontaneous
abortion after ingesting high doses. Still other
species, particularly chickens, appear even less
sensitive.
It has been demonstrated that zear-
alenone and its metabolites may cause car-
cinogenesis or teratogenesis in some species,
but further research is needed. Further
research is also needed with regard to human
toxicity. Currently, the International Agency
for Research on Cancer classifies zearalenone
as a 2A carcinogen, the highest possible classi-
fication when categorical human epidemiolo-
gy is absent. Several countries have already
established maximum allowable concentra-
tions of zearalenone in food ranging from 0
to 1,000 micrograms per kilogram. Data on
human toxicity are strongest with regard to
estrogenic effects. For example, zearalenone
was considered a possible etiological agent for
precocious pubertal changes that were
observed among Puerto Rican children for
several years beginning in 1979. Thousands
of children, some of whom were shown to
have zearalenone or its derivatives in their
blood, reportedly experienced symptoms.
However, as other estrogens (phytoestrogens
or residues ofanimal growth promoters) were
potentially present in the children's diets, this
outbreak might have stronger implications
with regard to zearalenone's contribution to
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the total environmental estrogen burden.
Recent investigations using in vitro systems
bolster the idea that zearalenone interacts
with human estrogen receptors. For example,
Craig Dees, a scientist in the Health
Sciences Research Division of the Oak
Ridge National Laboratory in
Tennessee, and colleagues reported
that zearalenone stimulates estro-
gen-receptor human breast
cancer cells to enter the
cell cycle in vitro
[EHP 105(suppl
3):633-636
(1997)].
"For
people
_ ~~~~~whoare
s tudying
endocrine dis-
ruptors and who are
actually looking for some
of the potential health effects
during development, this [myco-
toxin] is one oftheir concerns," says
Newbold. "But I certainly don't
think it has received the
attention for human
health that it should
have in the United
States."
With regard to
research, zearalenone
seems to be overshadowed by
deoxynivalenol, a more demonstrably toxic
Fusarium metabolite. This mycotoxin has
been linked to large-scale poisonings, human
disease, and animal production problems
throughout the world. Deoxynivalenol is one
ofthe most common mycotoxins contaminat-
ing grains. It belongs to a dass ofcompounds
called trichothecenes, to which several other
mycotoxins belong. Although deoxynivalenol
is the least toxicofthe trichothecenes, its toxi-
city is still substantial in both animals and
humans. Inlargeenough acutedoses, it causes
nausea, vomiting, and diarrhea and destroys
bloodcells. Animals, particularlypigs, demon-
strate feed refusal and weight loss at lower
doses. Deoxynivalenol has also been shown to
have immunological effects in animal models.
For example, research reviewed by James J.
Pestka, aprofessor offood science andhuman
nutrition at Michigan State University in East
Lansing, andcolleagues intheMay 1996issue
oftheJournalofToxicology andEnvironmental
Health demonstrates that deoxynivalenol
interferes with normal immune system func-
tioning in mice. Theyconduded thatdeoxyni-
valenol induces cytokines, immunesystemfac-
tors thathelp direct an inflammatory response.
In the
model they
reviewed,
mice exposed
to deoxynivalenol
developed symp-
toms similar to human
IgA nephropathy, a kid-
ney disorder characterized
byinflammation.
ExpandingFrontiers in
Mycotoxicology
Trichothecenes may also be at the root
of an outbreak of idiopathic pulmonary
hemorrhage among infants in Cleveland,
Ohio [EHP 107(suppl 3): 495-499 (1999)].
Among infants, pulmonary hemorrhage, or
episodes of bleeding in the lungs, can arise
from several causes such as injury or some
forms ofpneumonia. Unexplained, ongoing
episodes ofbleeding, as seen with the infant
patients in Cleveland, is much rarer. Between
1993 and 1998, physicians at the Rainbow
Babies & Children's Hospital in Cleveland
saw 37 cases of pulmonary hemorrhage
among infant patients; in the preceding 10
years, only three such cases had been encoun-
tered. Nearly all of the 37 infants were
brought to the hospital because ofbreathing
difficulties and required intensive care and
ventilator support. Pulmonary hemorrhage
wasn't always apparent before breathing diffi-
cultiessurfaced butwas detected once respira-
tory support began. Researchers suspected
that some element in the infants' home envi-
ronments was responsible for the symptoms
because in several cases symptoms recurred
when an infantreturned tohisorherhome.
In a case-control investigation begun in
November 1994 by the Centers for Disease
Control and Prevention, researchers found
evidence that the geographically clustered
infants' homes were contaminated with S.
chartarum, a mold not commonly found in
homeenvironments. S. chartarumis known to
produce several trichothecenes, specifically
satratoxins and roridin, aswell as phenylspiro-
drimanes, cyclosporin, andanewlydiscovered
class of compounds, the stachybocins.
Researchers hypothesized that themycotoxins,
in combination with other stressors in the
infants' environments such as tobacco smoke,
caused the respiratory ailment that daimed
thelives of12 ofthe37 infants. "Theprimary
problem with indoor molds is that the health
hazard ispredominandy linked to peoplewho
are atopic-that is, they tend to be allergic,"
says Dorr Dearborn, an associate professor of
pediatrics and biochemistry at the Case
Western Reserve University School of
Medicine in Cleveland and one of the
researchers associated with the ongoing S.
chartarum investigation. Says Dearborn,
"Whatwe'rebeginningto realize more recent-
ly, which is not reallywell known in the med-
ical field, is that there are [indoor] molds-
notjust Stachybotrys, but probably a larger list
ofthem-that produce mycotoxins that can
have direct effects on health. This is still an
area ofboth speculation/conjecture and some
knowledge, but it's an area ofactive concern
and with some research at least starting to be
generated."
The precise mechanisms of the
Stachybotrys mycotoxins are unknown,
explains Dearborn. The trichothecenes may
beable to triggeroraggravate an allergyprob-
lem directly, he says, but not through a tradi-
tional immunoglobulin E (lgE) pathway.
Typically, an allergic response involves pro-
duction of antibodies constructed from IgE
against the allergen and some form ofinflam-
mation (such as asthma). Pestka's work to
elucidate how deoxynivalenol induces
nephropathy has shown that, at low levels,
the trichothecene induces inflammatory
mediators. This suggests a mechanism by
which mycotoxins, induding those produced
by Stachybotrys, may produce airway disease
or skin reactions without going through the
typical IgEmechanisms, says Dearborn.
Further information on Stachybotrystoxi-
cityis gleaned from olderliteraturedescribing
agricultural exposures to the mold in Eastern
Europe and northern Russia during the
1940s and 1950s. In this literature, theeffects
include bleeding in the nose and throat
(although not the lungs), skin irritation, and
altered white blood cell counts. "The cellular
mechanism of trichothecenes is well estab-
lished: they are potent protein synthesis
inhibitors," says Dearborn. Inhibition occurs
via a single binding site on the ribosome, the
cellular location of protein construction.
Depending on the specific trichothecene,
construction breaks down during its initia-
tion, elongation, or termination stages, he
explains. However, he continues, the details
behind their effects on the immune system
remain unknown.
Dearborn and his associates are currently
in the early stages of a five-year grant from
the NIEHS to develop an infant model for
S. chartarum exposure as an outgrowth of
their investigations into the Cleveland out-
break ofidiopathic pulmonary hemorrhage.
"In the Cleveland situation we're dealing
with an epidemiological association-that
is, we've found [the mold] in the houses of
the cases more than we found it in the con-
trol houses. The link is not absolute at all;
it's simply an epidemiological link," says
Dearborn. One ofthe scientists' immediate
challenges comes in the form ofidentifying
a biomarker for exposure, a difficult task
given how rapidly the suspected toxins are
metabolized. Findinga biomarker is difficult
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because suspected Stachybotrys toxins
rapidly metabolized and most people d.
form antibodies in response to the
The researchers' earlv experiments to d
cate the disorder in infant animals hay
pronmising. "What we have shown is9
the spores of Stachybotiys are instilled
tracheas ofyouLng rat pups, they will
pulmonary hemorrhage. Initial res
gest that we are on the proper r
develop an infant model for the di
says Dearborn.
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Efforts to control exposure to mycotox-
ins are certainly better today than in ancient
times, but they still are not perfct iFor
example, the testing for mycotoxins as
aflatoxin o inv s grains tht ter
interstate c and thus does ro-
.rinedlocally grown cospU-
ations may face greater risk silause
they consume higher-than-aver ounts
of certain commodities or because they live
or work in poorly maintained buildings.
-Finally, research has primarily emphasized
dietary routes ofexposture. Knowledge about
the long-term effects of other exposures is
lacking. "The toxins that enter the crops we
use for food .. [ard] sort ofa by-product of
chemical warfare that's goinig onl at a micro-
biological level," says Miller. There are lots
of experiments to do, he Imutises, and nlot a
lot ofresoturces to do them.
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